149 related articles for article (PubMed ID: 38560074)
1. Effect of aspirin on cholesterol crystallization: A potential mechanism for plaque stabilization.
Fry L; Lee A; Khan S; Aziz K; Vedre A; Abela GS
Am Heart J Plus; 2022 Jan; 13():100083. PubMed ID: 38560074
[TBL] [Abstract][Full Text] [Related]
2. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization.
Abela GS; Vedre A; Janoudi A; Huang R; Durga S; Tamhane U
Am J Cardiol; 2011 Jun; 107(12):1710-7. PubMed ID: 21507364
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis.
Abela GS; Aziz K
Clin Cardiol; 2005 Sep; 28(9):413-20. PubMed ID: 16250264
[TBL] [Abstract][Full Text] [Related]
4. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.
Abela GS; Aziz K; Vedre A; Pathak DR; Talbott JD; Dejong J
Am J Cardiol; 2009 Apr; 103(7):959-68. PubMed ID: 19327423
[TBL] [Abstract][Full Text] [Related]
5. The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis.
Abideen ZU; Pathak DR; Sabanci R; Manu M; Abela GS
Front Cardiovasc Med; 2024; 11():1345521. PubMed ID: 38495937
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
Abela GS
J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
[TBL] [Abstract][Full Text] [Related]
7. Modeling of Mechanical Stress Exerted by Cholesterol Crystallization on Atherosclerotic Plaques.
Luo Y; Cui D; Yu X; Chen S; Liu X; Tang H; Wang X; Liu L
PLoS One; 2016; 11(5):e0155117. PubMed ID: 27149381
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy.
Abela GS; Aziz K
Scanning; 2006; 28(1):1-10. PubMed ID: 16502619
[TBL] [Abstract][Full Text] [Related]
9. Physical factors that trigger cholesterol crystallization leading to plaque rupture.
Vedre A; Pathak DR; Crimp M; Lum C; Koochesfahani M; Abela GS
Atherosclerosis; 2009 Mar; 203(1):89-96. PubMed ID: 18703195
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol crystal as a new feature of coronary vulnerable plaques: An optical coherence tomography study.
Nishimura S; Ehara S; Hasegawa T; Matsumoto K; Yoshikawa J; Shimada K
J Cardiol; 2017 Jan; 69(1):253-259. PubMed ID: 27156165
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid.
John Chapman M; Preston Mason R
Pharmacol Ther; 2022 Dec; 240():108237. PubMed ID: 35772589
[TBL] [Abstract][Full Text] [Related]
12. Interaction between bacteria and cholesterol crystals: Implications for endocarditis and atherosclerosis.
Boumegouas M; Raju M; Gardiner J; Hammer N; Saleh Y; Al-Abcha A; Kalra A; Abela GS
PLoS One; 2022; 17(2):e0263847. PubMed ID: 35180238
[TBL] [Abstract][Full Text] [Related]
13. Role of cholesterol crystals in atherosclerosis is unmasked by altering tissue preparation methods.
Nasiri M; Janoudi A; Vanderberg A; Frame M; Flegler C; Flegler S; Abela GS
Microsc Res Tech; 2015 Nov; 78(11):969-74. PubMed ID: 26278962
[TBL] [Abstract][Full Text] [Related]
14. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
Nidorf SM; Fiolet A; Abela GS
J Clin Lipidol; 2020; 14(5):619-630. PubMed ID: 32792218
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
Qin Z; Cao M; Xi X; Zhang Y; Wang Z; Zhao S; Tian Y; Xu Q; Yu H; Tian J; Yu B
Int J Cardiol; 2022 Oct; 364():162-168. PubMed ID: 35705168
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol Crystals are Associated with Carotid Plaque Vulnerability: An Optical Coherence Tomography Study.
Shi X; Cai H; Wang F; Liu R; Xu X; Li M; Han Y; Yin Q; Ye R; Liu X
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104579. PubMed ID: 31852598
[TBL] [Abstract][Full Text] [Related]
18. Killing the Culprit: Pharmacological Solutions to Get Rid of Cholesterol Crystals.
Iranshahy M; Banach M; Hasanpour M; Lavie CJ; Sahebkar A
Curr Probl Cardiol; 2022 Sep; 47(9):101274. PubMed ID: 35661813
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma.
Ho-Tin-Noé B; Vo S; Bayles R; Ferrière S; Ladjal H; Toumi S; Deschildre C; Ollivier V; Michel JB
J Pathol; 2017 Apr; 241(5):671-682. PubMed ID: 28039859
[TBL] [Abstract][Full Text] [Related]
20. Debris collected in-situ from spontaneously ruptured atherosclerotic plaque invariably contains large cholesterol crystals and evidence of activation of innate inflammation: Insights from non-obstructive general angioscopy.
Komatsu S; Yutani C; Takahashi S; Takewa M; Ohara T; Hirayama A; Kodama K
Atherosclerosis; 2022 Jul; 352():96-102. PubMed ID: 35300852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
